Remove 2023 Remove Electrophysiology Remove Technology
article thumbnail

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

DAIC

The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. Gery Tomassoni , Director of Electrophysiology at Baptist Health Lexington.

article thumbnail

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

DAIC

said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. 2, 2023 – found that therapy with the device was as safe and effective as conventional thermal ablation, with statistically shorter ablation times and a quick learning curve for physicians. physicians and patients alike," Reddy added.

Ablation 111
article thumbnail

Toward safer catheter-based electrophysiology procedures: First do no net harm!

HeartRhythm

2–4 In fact, the benefits and safety profile of AF ablation have resulted in its designation as first line therapy in the 2023 ACC/AHA/ACCP/HRS guideline for AF management.2 In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

This week, the Cleveland Clinic enrolled the first patient in the AVANT GUARD trial, overseen by Dr. Oussama Wazni, vice chair of cardiovascular medicine and section head, Cardiac Electrophysiology and Pacing, Cleveland Clinic, who is also serving as the lead investigator of the trial. Circulation.

article thumbnail

Implementing the 2023 Expert Consensus Statement: A Strategic Roadmap for Device Manufacturer Sales Representatives

Vector Remote

Implementing the 2023 Expert Consensus Statement: A Strategic Roadmap for Device Manufacturer Sales Representatives In the ever-evolving landscape of cardiac device care, keeping pace with guidelines and policies can often seem daunting.

article thumbnail

Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device?

DAIC

The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.

article thumbnail

UC San Diego Health First in Region to Implant Dual Chamber, Leadless Pacemaker

DAIC

Food and Drug Administration (FDA) in July 2023, a new leadless pacemaker system placed in both chambers of the heart and using a novel communication technology is now offering a more minimally invasive option for patients. Approved by the U.S. UC San Diego Health implanted the pacemaker system in the first patient in February 2024.

Pacemaker 105